[Management of atopic dermatitis in children].
D000293:Adolescent; D000367:Age Factors; D000486:Allergy and Immunology / Q000592:standards; D000890:Anti-Infective Agents / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D002648:Child; D002675:Child, Preschool; D003876:Dermatitis, Atopic / Q000175:diagnosis* / Q000453:epidemiology / Q000209:etiology / Q000628:therapy*; D003880:Dermatology / Q000379:methods / Q000592:standards; D005602:France / Q000453:epidemiology; D006634:Histamine H1 Antagonists / Q000627:therapeutic use; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007223:Infant; D007231:Infant, Newborn; D008487:Medical History Taking / Q000379:methods / Q000592:standards; D018579:Patient Selection; D010372:Pediatrics / Q000379:methods / Q000592:standards; D010808:Physical Examination / Q000379:methods / Q000592:standards; D012307:Risk Factors; D017592:Skin Care / Q000379:methods / Q000592:standards; D012882:Skin Tests
D000890:Anti-Infective Agents; D000893:Anti-Inflammatory Agents; D006634:Histamine H1 Antagonists; D007166:Immunosuppressive Agents